Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04650386 · ClinicalTrials.gov registry record · NA
Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients
A NA study, sponsored by Public Health Management Corporation.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT04650386 is a NA study that has completed, run by Public Health Management Corporation. The registered enrollment target is 125 participants.
The verdict
NCT04650386, a NA study, has completed, sponsored by Public Health Management Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to address important knowledge gaps regarding the optimal way to provide psychosocial treatment to patients who are receiving buprenorphine for opioid use disorder (OUD) in office-based settings. The project will develop and evaluate an adaptive treatment approach in which the interventions are delivered based on the individual needs of patients at baseline and throughout the course of care. The adaptive intervention will incorporate certified recovery specialists (CRSs) and cognitive behavioral therapy (CBT), two interventions that have been widely used in the treatment of OUD. The efficacy of the adaptive intervention will be evaluated through a randomized controlled trial (RCT) that will be conducted in federally qualified health (FQHCs) in Philadelphia.
Interventions
- BEHAVIORAL Psychosocial support determined by adaptive treatment algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04650386
The ClinicalTrials.gov registry entry for NCT04650386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Public Health Management Corporation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Psychosocial support determined by adaptive treatment algorithm is the first listed.
NCT04650386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04650386 about?
NCT04650386 is a clinical study titled "Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients". The purpose of this study is to address important knowledge gaps regarding the optimal way to provide psychosocial treatment to patients who are receiving buprenorphine for opioid use disorder (OUD) in office-based settings. The project will develop and evaluate an adaptive treatment approach in whi...
What is the current status of trial NCT04650386?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2020-09-21. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT04650386?
The interventions under investigation include: Psychosocial support determined by adaptive treatment algorithm (BEHAVIORAL).
Who is sponsoring clinical trial NCT04650386?
This trial is sponsored by Public Health Management Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.